🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The effect of multiple oral administration of two doses of CG5503 PR (prolo...
Status
Completed
Location
DE001 - Contract research organisation
Start Date
2003-03
Trial ID
NCT03951402
This study is being performed to investigate the potential for AZD5672 to a...
Status
Completed
Location
Research Site
Start Date
2009-04
Trial ID
NCT00887770
This was a double-blind, randomized, placebo- and positive-controlled, para...
Status
Completed
Location
Parexel Early Phase Clinical Unit (Los Angeles)
Start Date
2021-08-05
Trial ID
NCT05046132
Treatments Being Tested
This was a single-center, multiple-dose, randomized, double-blind, placebo-...
Status
Completed
Location
PRA International Clinical Pharmacology Center (EDS US Clinic)
Start Date
2019-02-07
Trial ID
NCT03808298
Treatments Being Tested
The purpose of the study is to evaluate the effects of clinical and high cl...
Status
Completed
Location
ICON Lenexa
Start Date
2023-04-12
Trial ID
NCT05818852
Treatments Being Tested
The main aim of this study is to find out how more than one dose of TAK-279...
Status
Completed
Location
Celerion
Start Date
2024-04-29
Trial ID
NCT06258265
Treatments Being Tested
This is a Phase 1, single centre, randomised, double blind (except for moxi...
Status
Completed
Location
Covance Clinical Research Unit (CRU) Ltd
Start Date
2018-06-15
Trial ID
NCT03577275
Treatments Being Tested
This study is to evaluate the effects of single therapeutic and supratherap...
Status
Completed
Location
Celerion
Start Date
2016-04-01
Trial ID
NCT04867980
Treatments Being Tested
The main purpose of this study is to examine the effect of dapagliflozin on...
Status
Completed
Location
Research Site
Start Date
2007-07
Trial ID
NCT00688493
Treatments Being Tested
The objective of this study was to evaluate the effects of cebranopadol (GR...
Status
Completed
Location
US001 Contract research organization
Start Date
2013-07-10
Trial ID
NCT03958123